oral tirzepatide studies Safety and efficacy of as an add-on to single antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial tirzepatide vs semaglutide safety comparison

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved its use, and it is increasingly prescribed for glycaemic control

Take a new needle and remove the paper tab

Never restart Ozempic at a higher dose than you were previously taking without medical supervision, as dose escalation should always follow the licensed titration schedule to minimise adverse effects

The total number of GLP-1-prescribing providers increased by 228% from July 2020 to May 2023

Kliniks specialization in prior authorization processes ensures we handle all necessary paperwork and communication with your insurance provider